These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 18701526)

  • 1. Argatroban anticoagulation in intensive care patients: effects of heart failure and multiple organ system failure.
    Begelman SM; Baghdasarian SB; Singh IM; Militello MA; Hursting MJ; Bartholomew JR
    J Intensive Care Med; 2008; 23(5):313-20. PubMed ID: 18701526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of critical illness and organ failure on therapeutic argatroban dosage requirements in patients with suspected or confirmed heparin-induced thrombocytopenia.
    Keegan SP; Gallagher EM; Ernst NE; Young EJ; Mueller EW
    Ann Pharmacother; 2009 Jan; 43(1):19-27. PubMed ID: 19116377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Argatroban therapy in heparin-induced thrombocytopenia with hepatic dysfunction.
    Levine RL; Hursting MJ; McCollum D
    Chest; 2006 May; 129(5):1167-75. PubMed ID: 16685006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Argatroban therapy for heparin-induced thrombocytopenia in ICU patients with multiple organ dysfunction syndrome: a retrospective study.
    Saugel B; Phillip V; Moessmer G; Schmid RM; Huber W
    Crit Care; 2010; 14(3):R90. PubMed ID: 20487559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of renal function on argatroban therapy in heparin-induced thrombocytopenia.
    Guzzi LM; McCollum DA; Hursting MJ
    J Thromb Thrombolysis; 2006 Dec; 22(3):169-76. PubMed ID: 17103051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Argatroban anticoagulation in patients with heparin-induced thrombocytopenia requiring renal replacement therapy.
    Reddy BV; Grossman EJ; Trevino SA; Hursting MJ; Murray PT
    Ann Pharmacother; 2005 Oct; 39(10):1601-5. PubMed ID: 16131539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced argatroban doses after coronary artery bypass graft surgery.
    Hoffman WD; Czyz Y; McCollum DA; Hursting MJ
    Ann Pharmacother; 2008 Mar; 42(3):309-16. PubMed ID: 18303137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Argatroban for suspected heparin-induced thrombocytopenia: contemporary experience at a large teaching hospital.
    Kodityal S; Nguyen PH; Kodityal A; Sherer J; Hursting MJ; Rice L
    J Intensive Care Med; 2006; 21(2):86-92. PubMed ID: 16537750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of diagnostic tests and argatroban or lepirudin therapy in patients with suspected heparin-induced thrombocytopenia.
    Kiser TH; Jung R; MacLaren R; Fish DN
    Pharmacotherapy; 2005 Dec; 25(12):1736-45. PubMed ID: 16305293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Weight-based argatroban dosing nomogram for treatment of heparin-induced thrombocytopenia.
    Ansara AJ; Arif S; Warhurst RD
    Ann Pharmacother; 2009 Jan; 43(1):9-18. PubMed ID: 19126826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Argatroban dosage requirements and outcomes in intensive care versus non-intensive care patients.
    Smythe MA; Koerber JM; Forsyth LL; Priziola JL; Balasubramaniam M; Mattson JC
    Pharmacotherapy; 2009 Sep; 29(9):1073-81. PubMed ID: 19698012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Argatroban therapy in women with heparin-induced thrombocytopenia.
    Jang IK; Baron SJ; Hursting MJ; Anglade E
    J Womens Health (Larchmt); 2007; 16(6):895-901. PubMed ID: 17678460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Argatroban dosing in patients with heparin-induced thrombocytopenia.
    Verme-Gibboney CN; Hursting MJ
    Ann Pharmacother; 2003; 37(7-8):970-5. PubMed ID: 12841802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Argatroban anticoagulation in critically ill patients.
    Beiderlinden M; Treschan TA; Görlinger K; Peters J
    Ann Pharmacother; 2007 May; 41(5):749-54. PubMed ID: 17440009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Argatroban anticoagulation for heparin-induced thrombocytopenia in elderly patients.
    Bartholomew JR; Pietrangeli CE; Hursting MJ
    Drugs Aging; 2007; 24(6):489-99. PubMed ID: 17571914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Argatroban therapy in pediatric patients requiring nonheparin anticoagulation: an open-label, safety, efficacy, and pharmacokinetic study.
    Young G; Boshkov LK; Sullivan JE; Raffini LJ; Cox DS; Boyle DA; Kallender H; Tarka EA; Soffer J; Hursting MJ
    Pediatr Blood Cancer; 2011 Jul; 56(7):1103-9. PubMed ID: 21488155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Argatroban therapy for heparin-induced thrombocytopenia in acutely ill patients.
    Gray A; Wallis DE; Hursting MJ; Katz E; Lewis BE
    Clin Appl Thromb Hemost; 2007 Oct; 13(4):353-61. PubMed ID: 17911186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Argatroban for anticoagulation in continuous renal replacement therapy.
    Link A; Girndt M; Selejan S; Mathes A; Böhm M; Rensing H
    Crit Care Med; 2009 Jan; 37(1):105-10. PubMed ID: 19050602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A case series describing the use of argatroban in patients on extracorporeal circulation.
    Cornell T; Wyrick P; Fleming G; Pasko D; Han Y; Custer J; Haft J; Annich G
    ASAIO J; 2007; 53(4):460-3. PubMed ID: 17667231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Argatroban anticoagulation in patients with heparin-induced thrombocytopenia.
    Lewis BE; Wallis DE; Leya F; Hursting MJ; Kelton JG;
    Arch Intern Med; 2003 Aug 11-25; 163(15):1849-56. PubMed ID: 12912723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.